TB-500: What the Research Shows on Tissue Repair

TB-500 is a synthetic analogue of Thymosin Beta-4, naturally involved in actin polymerisation, cell migration, and wound healing. It has been studied for systemic rather than local activity, with research examining repair across multiple tissue types.

By UAE Peptide Clinic Research Desk

TB-500 is a synthetic analogue of Thymosin Beta-4, a naturally occurring protein involved in actin polymerisation, cell migration, and wound healing. It is distinguished from many repair peptides in research by its proposed systemic action: rather than acting only at a site of injury, it circulates, and studies have examined its effects across multiple tissue types.

Mechanism of Action

Thymosin Beta-4 binds to G-actin (monomeric actin) and sequesters it, regulating cytoskeletal dynamics and cell motility. TB-500, the active fragment of this protein, shares this actin-binding activity and has been studied in preclinical models for roles in angiogenesis, inflammation, cardiac tissue repair, and wound closure. Its proposed systemic action is why it has attracted research interest in relation to multiple sites of injury.

What the Research Shows

TB-500 has been studied in cardiac repair models (following myocardial infarction), wound healing including corneal and dermal repair, and musculoskeletal recovery. Animal studies have reported reduced inflammation and faster functional recovery. It has also been used in veterinary medicine, particularly in racehorses, although human clinical data remain limited.

Areas of Research Interest

Research interest in TB-500 has focused on tendon and ligament injury, post-surgical tissue repair, and recovery where multiple tissue systems are under stress. It is often discussed alongside BPC-157 in the so-called Wolverine Stack.

  • Studied in preclinical models of cardiac, dermal, corneal and musculoskeletal repair
  • Proposed systemic rather than local action
  • Often discussed alongside BPC-157 in combination research
  • Protocol length and dosing are set by the prescribing physician

Whether any protocol is appropriate is a decision for an independent DHA-licensed physician. Read more on the TB-500 page.

If you want to understand whether any of this is relevant to you, an independent DHA-licensed physician can review your case. Take the two-minute quiz at /find-my-stack or book a physician consultation at /book (AED 300 deposit, credited to your first order).

The Protocols Company